The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.1 - Manufacture of basic pharmaceutical products
119 jobs Number of planned job losses
Announcement Date
30 August 2012
Employment effect (start)
30 September 2012
Foreseen end date
31 December 2012
Description
Manufacturer of pharmaceutical products Expanscience announced that it is to cut up to 119 jobs. The company justified this move by referring to a decision by the French government, which is expected to impact the sales of one of Expanscience's main drugs (Piasclédine 300) negatively.
The process of information and consultation on the voluntary departure plan is expected to be concluded by the end of September. The restructuring is met by heavy criticism from union side, as it is based on a ‘hypothetical' legislative change the French government has yet to approve.
Expanscience manufactures pharmaceutical products under the brand Mustela.
Eurofound (2012), Laboratoires Expanscience, Internal restructuring in France, factsheet number 74055, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/74055.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
